Trials / Unknown
UnknownNCT00899119
Collecting Stem Cells in Patients With Waldenstrom's Macroglobulinemia
Autologous Stem Cell Harvesting for Waldenstrom's Macroglobulinemia
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 40 (estimated)
- Sponsor
- Herbert Irving Comprehensive Cancer Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
RATIONALE: Collecting and storing stem cells to study in the laboratory may help doctors learn more about collecting stem cells from patients who have undergone treatment for Waldenstrom's macroglobulinemia. PURPOSE: This laboratory study is collecting stem cells from patients with Waldenstrom's macroglobulinemia.
Detailed description
OBJECTIVES: * Harvest and store adequate CD34+ stem cells from patients with Waldenstrom's macroglobulinemia (WM) for potential future use in transplantation strategies. * Evaluate the ability to harvest stem cells after therapy for WM (e.g., fludarabine-based chemotherapy) by evaluating the number of days to adequate harvest. * Collect aliquots of stem cells for future research analysis as part of a WM database project. OUTLINE: Patients undergo collection of autologous stem cells beginning on day 4 or 5 and continuing until an adequate number of stem cells are collected. Cells are then cryopreserved. PROJECTED ACCRUAL: A total of 40 patients will be accrued for this study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | leukapheresis |
Timeline
- Start date
- 2005-11-01
- First posted
- 2009-05-12
- Last updated
- 2013-12-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00899119. Inclusion in this directory is not an endorsement.